Nurses - Medscape
3 days ago · Nurses : Welcome to Medscape Nurses, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text journal articles, and trending stories.
Cardiology News & Opinion – theheart.org - Medscape
Cardiology : Welcome to theheart.org | Medscape Cardiology, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text journal articles ...
Point-of-Care Medical Reference App For Doctors - Medscape
2 days ago · Check drug interactions, access 450+ medical calculators, and ID pills at the point-of-care with Medscape's official app. No hidden costs or subscription fees.
Psychiatry - Medscape
Psychiatry : Welcome to Medscape Psychiatry, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text journal articles, and trending ...
FDA Approves 'Female Viagra' Flibanserin ( Addyi ) - Medscape
Aug 18, 2015 · Flibanserin (Addyi) — also known as "Female Viagra" or "Pink Viagra" — will be marketed by Sprout Pharmaceuticals. It is approved to treat premenopausal women. The nonhormonal therapy — a 5 ...
Oncology - Medscape
Oncology : Welcome to Medscape Oncology, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text journal articles, and trending stories.
New Oral Weight Loss Drugs: Where Are We and What's Next?
June 05, 2024. 0. Now that semaglutide (Wegovy), tirzepatide (Zepbound), and other injectables have created an insatiable market for weight loss drugs, biotech and pharmaceutical companies are ...
Physician Compensation Report 2023 - Medscape
: The Medscape Physician Compensation Report is the physician-preferred salary report, based on the most comprehensive and widely used doctors’ salary survey in the US for the 13th straight year.
FDA Moves Generic Dapagliflozin a Step Closer to US Sales
Feb 23, 2022 · The FDA added two different dose formulations of this generic dapagliflozin, 5 mg and 10 mg, to the agency's list of Approved Drug Products With Therapeutic Equivalence Evaluations, a publication ...
2024 Will See Major Advances in Glaucoma Care - Medscape
2024 Will See Major Advances in Glaucoma Care. Richard Mark Kirkner. February 08, 2024. 0. Dry eye and glaucoma may be the two most confounding conditions ophthalmologists face. Late last year ...